⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10634919 | 1.00 | — | — | |
| SCHEMBL40620 | 1.00 | — | — | |
| SCHEMBL28920328 | 0.97 | — | — | |
| SCHEMBL5160576 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL27929205 | 0.97 | — | — | |
| SCHEMBL5159552 | 0.97 | — | — | |
| Water SCHEMBL10355698 | 0.97 | — | — | |
| Acetic Acid SCHEMBL5575637 | 0.95 | CA2 (0.50) | — | |
| Water SCHEMBL5159514 | 0.95 | CA2 (0.50) | — | |
| Methylene Chloride SCHEMBL8416036 | 0.92 | CA2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11268966-B2 | Biomarkers of autism spectrum disorder | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2022-03-08 | — | — | US | disclosed |
| EP-3019624-B1 | BIOMARKERS OF AUTISM SPECTRUM DISORDER | STEMINA BIOMARKER DISCOVERY INC (US) | 2020-09-16 | — | — | EP | disclosed |
| CN-110167944-A | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | 利奥制药有限公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-110088108-A | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 利奥制药有限公司 | 2019-08-02 | — | — | CN | disclosed |
| US-20190072569-A1 | BIOMARKERS OF AUTISM SPECTRUM DISORDER | STEMINA BIOMARKER DISCOVERY, INC. | 2019-03-07 | — | — | US | disclosed |
| US-10060932-B2 | Biomarkers of autism spectrum disorder | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2018-08-28 | — | — | US | disclosed |
| US-20170354713-A1 | FGF21 Derivatives and Uses Thereof | NOVO NORDISK AS (DK) | 2017-12-14 | — | — | US | disclosed |
| US-20160169915-A1 | BIOMARKERS OF AUTISM SPECTRUM DISORDER | STEMINA BIOMARKER DISCOVERY, INC. | 2016-06-16 | — | — | US | disclosed |
| EP-3019624-A2 | BIOMARKERS OF AUTISM SPECTRUM DISORDER | Stemina Biomarker Discovery, Inc. (US) | 2016-05-18 | — | — | EP | disclosed |
| WO-2016021192-A1 | PROCESS FOR PRODUCTION OF (S)-(TETRAHYDROFURAN-3-YL)HYDRAZINE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2016-02-11 | — | — | WO | disclosed |
| WO-2011132083-A2 | NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES | ACTAVIS GROUP PTC EHF (IS) | 2011-10-27 | — | — | WO | disclosed |
| CN-102131773-A | Method for producing paricalcitol | AZAD PHARMACEUTICAL INGREDIENT | 2011-07-20 | — | — | CN | disclosed |
| EP-2268319-A2 | PRECURSORS OF LIPID METABOLISM FOR THE DIAGNOSIS AND TREATMENT OF CANCER | Universität Ulm (DE) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009109798-A2 | PRECURSORS OF LIPID METABOLISM FOR THE DIAGNOSIS AND TREATMENT OF CANCER | UNIVERSITÄT ULM (DE) | 2009-09-11 | — | — | WO | disclosed |
| US-20090203583-A1 | Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| CN-101151265-A | Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent | LG LIFE SCIENCES LTD (KR) | 2008-03-26 | — | — | CN | disclosed |
| EP-1539492-A1 | HIGH SPEED NEGATIVE-WORKING THERMAL PRINTING PLATES | Kodak Polychrome Graphics, LLC (US) | 2005-06-15 | — | — | EP | disclosed |
| CN-1527830-A | Ether derivatives useful as inhibitors of PDE4 isozymes | �Ʒ� | 2004-09-08 | — | — | CN | disclosed |
| WO-2004014652-A1 | HIGH SPEED NEGATIVE-WORKING THERMAL PRINTING PLATES | KODAK POLYCHROME GRAPHICS LLC (US) | 2004-02-19 | — | — | WO | disclosed |
| US-4734367-A | OPTICALLY ACTIVE INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 1988-03-29 | — | — | US | disclosed |